WHO grants emergency use to COVID-19 vaccine developed by China's Sinopharm
The World Health Organization said Friday it has listed the COVID-19 vaccine developed by China's Sinopharm for emergency use, allowing it to be rolled out across the world. The vaccine, which is made by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group, "has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk," said Dr MariÃƒÂ¢ngela SimÃƒÂ£o, WHO Assistant-Director General for Access to Health Products. SimÃƒÂ£o said the agency will encourage the manufacturer to participate in the WHO's Covax program, which aims to get vaccines to poorer countries, that are lagging in the global vaccine push due to a lack of supply. The WHO has already granted emergency use authorization to vaccines developed by
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
May 07, 2021 11:53 ET (15:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.